secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vir Biotechnology, Inc. (VIR)
CIK:        0001706431
Form:       8-K
Filed at:   2026-03-04T23:59:59+00:00
Accession:  0001193125-26-091447
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Vir Bio appoints CEO Marianne De Backer to additional role of President
-----------------------------------------------------------------------

- On March 4, 2026, Vir Bio's Board appointed CEO Marianne De Backer to the additional position of President.
- No arrangements or understandings exist between Dr. De Backer and any person regarding her appointment as President.
- No family relationship between Dr. De Backer and any Vir Bio director or executive officer.
- Dr. De Backer has no direct or indirect interest in any transaction requiring Item 404(a) disclosure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1706431/000119312526091447/0001193125-26-091447-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1706431/000119312526091447/d88412d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-091447

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer